[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 175
Citations 0
Invited Commentary
November 2016

Topical Furosemide Possibly Beneficial for Reducing Recurrence Rates After Nasal Polyp Surgery

Author Affiliations
  • 1US Institute for Advanced Sinus Care and Research, Columbus, Ohio
JAMA Otolaryngol Head Neck Surg. 2016;142(11):1049-1050. doi:10.1001/jamaoto.2016.1632

Chronic rhinosinusitis remains one of the most costly chronic diseases to treat in the United States, with an estimated economic burden of greater than $60 billion. Chronic rhinosinusitis with nasal polyposis is one of the most difficult subsets of the condition to manage, often requiring multiple surgical procedures because there are no safe and effective medical therapies to prevent polyp formation. Oral steroids and intranasal steroid irrigations remain the mainstay of the medical therapy for patients with nasal polyposis, but the adverse effects of long-term steroid use are harmful across multiple organ systems, and the risks for both the common adverse effects as well as the rare and idiosyncratic devastating adverse effects appear to increase with the accumulated dose of steroids over a person’s lifetime. As a result, the need for new, safe, and effective medical therapies remains a pressing priority for the treatment of chronic rhinosinusitis with nasal polyposis.

First Page Preview View Large
First page PDF preview
First page PDF preview
×